Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Suzhou Basecare Medical Corp. Ltd. Class H ( (HK:2170) ) has issued an update.
Suzhou Basecare Medical Corporation Limited announced that it has received Class III medical device registration approval from China’s National Medical Products Administration for its Geri Medium, part of the Gems series embryo culture media. The product, already certified by CE, FDA and TGA, is used in combination with the Geri Wet Time-Lapse incubator and an AI embryo assessment system to address embryo culture challenges in older patients through a triple antioxidant protection system and a stable osmotic environment.
The NMPA approval enables the localized production of this high-end assisted reproductive consumable in China, filling a domestic gap and marking a shift from technology import to local manufacturing for the company. With this approval, Basecare becomes the first enterprise in China to hold FDA, CE, TGA and NMPA certifications in this segment, reinforcing its competitive advantage in assisted reproduction and strengthening its ecosystem built on core PGT technology and self-sufficient consumables supply.
The most recent analyst rating on (HK:2170) stock is a Sell with a HK$2.00 price target. To see the full list of analyst forecasts on Suzhou Basecare Medical Corp. Ltd. Class H stock, see the HK:2170 Stock Forecast page.
More about Suzhou Basecare Medical Corp. Ltd. Class H
Suzhou Basecare Medical Corporation Limited is a China-based medical device company specializing in assisted reproductive technologies, particularly preimplantation genetic testing (PGT) and related consumables. The Group serves the majority of licensed PGT institutions across China and operates numerous localized laboratories, building an ecosystem around high-end fertility solutions.
Average Trading Volume: 144,474
Technical Sentiment Signal: Sell
Current Market Cap: HK$508.8M
Find detailed analytics on 2170 stock on TipRanks’ Stock Analysis page.